symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
MDWD,8.33,0.992395,19128,78923918,0,7.1-14.58,-0.42,MediWound Ltd.,USD,0001593984,IL0011316309,M68830104,NASDAQ Global Market,NASDAQ,Biotechnology,https://www.mediwound.com,"MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.",Mr. Ofer  Gonen B.Sc.,Healthcare,IL,83,972 7 797 14100,42 Hayarkon Street,Yavne,,8122745,12.254,1.91595,https://financialmodelingprep.com/image-stock/MDWD.png,2014-03-20,False,False,True,False,False
